← Open Payments lookup

RICHARD HALL: Open Payments

NPI 1134871643 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,767 in 197 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $342 · 2025 $3,767

Food & beverage: $3,658Education: $109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$629
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$588
E.R. Squibb & Sons, L.L.C.25$452
Vanda Pharmaceuticals Inc.15$414
Teva Pharmaceuticals USA, Inc.23$376
Alkermes, Inc.19$360
Otsuka America Pharmaceutical, Inc.14$234
ABBVIE INC.24$219
Lundbeck LLC10$202
Axsome Therapeutics, Inc.7$162

Products named: INGREZZA, CAPLYTA, COBENFY, FANAPT, ARISTADA, VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA.

Industry payments across AL — which companies pay providers there.